# VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension

> **NCT01889966** · PHASE4 · COMPLETED · sponsor: **Kerckhoff Heart Center** · enrollment: 10 (actual)

## Conditions studied

- Pulmonary Hypertension Associated With Connective Tissue Disease

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT01889966
- **Lead sponsor:** Kerckhoff Heart Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01889966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01889966, "VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01889966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
